Translational Development Acquisition Corp. (TDACW)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$944.5K | -$196.4K | -$485.6K | — |
| Net Income | $6.36M | -$71.0K | -$485.6K | — |
| Total Assets | $181.70M | $175.00M | $2.0K | — |
| Total Liabilities | $6.58M | $6.25M | $509.7K | — |
| Shareholders' Equity | -$6.54M | -$5.60M | -$507.7K | -$22.1K |
| Cash & Equivalents | $29.8K | $438.2K | $2.0K | — |
| Operating Cash Flow | -$608.4K | -$851.4K | -$204 | — |
| Shares Outstanding | — | 0 | 0 | — |